tert-butyl (S)-3-(4-bromophenyl)piperidine-1-carboxylate

Min.Order / FOB Price:Get Latest Price

1 Kilogram	Negotiable

1 Kilogram

Negotiable

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,T/T

Keywords

Niraparib (N481400) intermediate Manufacturer (audit and TDP support) Commercial production

Quick Details

Appearance:syrup form
Application:It is an intermediate of Niraparib (N481400), a novel oral poly (ADP-ribose) polymerase (PARP) inhibitor effective in BRCA-1 and -2 mutant tumors
PackAge:standard package
ProductionCapacity:commercial production|Metric Ton|Day
Storage:room temperature
Transportation:Non-hazardous

Superiority:

Niraparib (N481400) intermediate with wide usage

Commercial production from grams to hundreds kgs, with technical documents package support, and audit and inspection support.

With high purity and optimized and stable process.

Self Innovation

Details:

MW:340.26

SENOVA PHARMA is committed to the development and production of API’s and advanced intermediates. We develop every intermediate process from the first step to API.

We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.

Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions， esp in anti-tumor and anti-cancer fields.

View All